Ostro Unveils Airmark to Transform Static Pharma Emails into Dynamic, Compliant Conversational AI Ostro, an AI-powered engagement platform already trusted by more than half of the top 20 global pharmaceutical…
Walgreens Embarks on New Era as Private Standalone Company Following Acquisition by Sycamore Partners Walgreen Co. (“Walgreens” or “the Company”), one of America’s most iconic retail pharmacy chains and a…
Thermo Fisher Scientific Honored with Three R&D 100 Awards for Innovations Transforming Precision Medicine, Cell Therapy, and Biopharmaceutical Research Thermo Fisher Scientific Inc. (NYSE: TMO), the global leader in serving…
Enveric Biosciences Advances Neuropsychiatric Pipeline with Successful Completion of Dose Range Finding Studies for Lead Candidate EB-003 Enveric Biosciences, Inc. (NASDAQ: ENVB), a biotechnology company pioneering next-generation neuroplastogenic small-molecule therapeutics,…
Hope Biosciences Receives FDA RMAT Designation for Stem Cell Therapy in Relapsing-Remitting Multiple Sclerosis Hope Biosciences, a leading U.S.-based stem cell banking and cellular therapeutics manufacturer, has announced a major…
DNAnexus Expands Leadership to Drive AI Innovation and Biopharma Growth DNAnexus, Inc., a leader in enterprise solutions for precision health data, has unveiled a series of strategic leadership appointments that…
Tasso and SheMed Partner to Deliver At-Home Blood Testing for Safer, Personalized GLP-1 Treatments in the UK In a move that could transform how women access and experience weight loss…
Fresenius Leads EASYGEN Consortium to Decentralize CAR-T Cell Therapy and Improve Patient Access Across Europe The global healthcare company Fresenius has announced the launch of a major new initiative aimed…
Insulet Elevates Eric Benjamin to Chief Operating Officer and Appoints Manoj Raghunandanan as Chief Growth Officer, Strengthening Leadership to Drive Next Phase of Global Expansion Insulet Corporation (NASDAQ: PODD), the…
Varian Completes Enrollment and Treatment in FAST-02 Clinical Trial, Marking Major Milestone for Flash Radiotherapy in Thoracic Bone Metastases Varian, a Siemens Healthineers company and a global leader in radiation…
Evolus Reports Positive Pivotal Trial Data for Evolysse™ Sculpt Hyaluronic Acid Gel at 2025 Cosmetic Bootcamp, Marking a Major Milestone in Aesthetic Innovation Evolus, Inc. (NASDAQ: EOLS), a fast-growing performance…
Merz Therapeutics Advances Migraine Research With Enrollment of First Patients in Two Global Phase III Clinical Trials for XEOMIN® (incobotulinumtoxinA) Merz Therapeutics GmbH, a neurology-focused specialty pharmaceutical company, announced a…